Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Iakov N. Rudenko
Observed names:
I. N. Rudenko,
Iakov N Rudenko,
Iakov Rudenko,
Iakov N. Rudenko
Observed institutions:
National Institutes of Health,
Russian Academy of Sciences,
State University of New York,
Pavlov Institute of Physiology of the Russian Academy of Sciences,
National Institute on Aging,
Stony Brook University
show all 6
OpenAlex ID:
A5000789556
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
2014
·
Alexandria Beilina
, Iakov N. Rudenko
, et al.
·
Proceedings of the National Academy of Sciences
·
357
Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
2014
·
Guoxiang Liu
, Jia Yu
, et al.
·
Journal of Clinical Investigation
·
166
PDF
mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex
2013
·
Allissa A Dillman
, David N Hauser
, et al.
·
Nature Neuroscience
·
148
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
2012
·
Iakov N. Rudenko
, Alice Kaganovich
, et al.
·
Biochemical Journal
·
120
Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
2014
·
Ruth Chia
, Sara Haddock
, et al.
·
Nature Communications
·
103
PDF
Hexokinase activity is required for recruitment of parkin to depolarized mitochondria
2013
·
Melissa K. McCoy
, Alice Kaganovich
, et al.
·
Human Molecular Genetics
·
97
PDF
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
2013
·
Evy Lobbestael
, Jing Zhao
, et al.
·
Biochemical Journal
·
96
Is Inhibition of Kinase Activity the Only Therapeutic Strategy for LRRK2-associated Parkinson's Disease?
2012
·
Iakov N Rudenko
, Ruth Chia
, et al.
·
BMC Medicine
·
64
PDF
Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
2014
·
Iakov N. Rudenko
, Mark R. Cookson
·
Neurotherapeutics
·
55
PDF
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
2018
·
Laura Pellegrini
, David N Hauser
, et al.
·
Human Molecular Genetics
·
54
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2
2017
·
Iakov N. Rudenko
, Alice Kaganovich
, et al.
·
Biochemical Journal
·
38
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research
2016
·
Rebekah G. Langston
, Iakov N. Rudenko
, et al.
·
Biochemical Journal
·
28
14-3-3 proteins are promising LRRK2 interactors
2010
·
Iakov N. Rudenko
, Mark R. Cookson
·
Biochemical Journal
·
23
Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2
2018
·
Rebekah G. Langston
, Iakov N. Rudenko
, et al.
·
Neurochemical Research
·
19
Effects of lithium on isolated rat heart mitochondria
2010
·
S. M. Korotkov
, V. P. Nesterov
, et al.
·
Doklady Biochemistry and Biophysics
·
2
Untitled
2021
·
I. S. Savka
, S. A. Sapa
, et al.
·
Current aspects of military medicine Сучасні аспекти військової медицини
PDF
Show more works
View as search
Works count:
16
Citation count:
1,370
H-index:
14
I10-index:
14
Year
Topic
Type